|1|Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube. (24100801)
|2|MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor. (23135210)
Halon A.... Surowiak P.
|3|Laparoscopic staging for apparent early stage ovarian or fallopian tube cancer. First case series from a UK cancer centre and systematic literature review. (23721765)
Brockbank E.C.... Barton D.P.
|4|Independent radiologic review of the Gynecologic Oncology Group Study 0218, a phase III trial of bevacizumab in the primary treatment of advanced epithelial ovarian, primary peritoneal, or fallopian tube cancer. (23906656)
Burger R.A.... Bookman M.A.
|5|Early detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity. (23868002)
Otsuka I.... Hoshi K.
|6|Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in brca;tp53;pten models. (24332043)
Perets R.... Drapkin R.
|7|OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer. (22529265)
Aghajanian C.... Nycum L.R.
|8|Outcome of single agent generic gemcitabine in platinum-resistant ovarian cancer, fallopian tube cancer and primary peritoneal adenocarcinoma. (22524817)
Suprasert P.... Manopunya M.
|9|Multidrug resistance gene (MDR-1) and risk of brain metastasis in epithelial ovarian, fallopian tube, and peritoneal cancer. (20921883)
Matsuo K.... Sood A.K.
|10|Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer. (21992853)
Coleman R.L.... Sood A.K.
|11|Para-aortic lymphadenectomy for primary fallopian tube cancer. (20887989)
Koo Y.J.... Mok J.E.
|12|Primary fallopian tube cancer in term pregnancy: a case report. (21614918)
Le A.... Wang Z.
|13|Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study. (21815133)
McGonigle K.F.... Malpass T.W.
|14|Phase I study of pemetrexed and pegylated liposomal doxorubicin in patients with refractory breast, ovarian, primary peritoneal, or fallopian tube cancer. (20352294)
Richards D.A.... Tai D.F.
|15|Expression of Semaphorin 3F and Its Receptors in Epithelial Ovarian Cancer, Fallopian Tubes, and Secondary MA1llerian Tissues. (20041133)
Drenberg C.D.... Nicosia S.V.
|16|A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. (19264351)
Schmeler K.M.... Freedman R.S.
|17|Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. (19826113)
Matulonis U.A.... Penson R.T.
|18|Phase II evaluation of nanoparticle albumin-bound paclitaxel in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer. (19224848)
Teneriello M.G.... Asmar L.
|19|Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. (19543244)
Shaw P.A.... Begley H.
|20|Fallopian tube cancer presenting as inflammatory breast carcinoma: report of a case and review of the literature. (19899419)
Papakonstantinou K.... Fotiou S.
|21|Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia. (18423560)
Nimeiri H.S.... .
|22|A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. (18342932)
Folkins A.K.... Crum C.P.
|23|Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. (19006196)
Wethington S.L.... Wright J.D.
|24|Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer. (18554701)
Onujiogu N.... Yamada S.D.
|25|Primary fallopian tube cancer may mimic endometrial malignancy. (18603511)
Lin C.K.... Yu M.H.
|26|The incidence of primary fallopian tube cancer in the United States. (17961642)
Stewart S.L.... Michaud F.
|27|Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer. (17614125)
Black D.... Abu-Rustum N.R.
|28|First report of primary fallopian tube cancer diagnosed by liquid-based cytology in an asymptomatic woman. (17877777)
Benjamin R.... Kirwan J.
|29|A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. (16445606)
Benoit M.F.... Hannigan E.V.
|30|The founder mutation BRCA1c.2845insA identified in a fallopian tube cancer patient: a case report. (16515624)
Damayanti Z.... Sng J.H.
|31|Inguinal node metastasis as the initial presentation of primary fallopian tube cancer. (16876236)
Cho J.... DA-az-Montes T.P.
|32|BRCA2 germline mutations in primary cancer of the fallopian tube. (15254695)
Casarsa S.... Damante G.
|33|Phase 2 trial of interferon-beta as second-line treatment of ovarian cancer, fallopian tube cancer, or primary carcinoma of the peritoneum. (15331919)
Markman M.... Lindner D.
|34|Primary fallopian tube cancer--a ten year review. Clinicopathological study of 12 cases. (15285322)
Liapis A.... Creatsas G.
|35|Preoperative diagnosis of fallopian tube cancer by imaging. (14628888)
Mikami M.... Fukuiya T.
|36|A novel Q3034R BRCA2 germline mutation identified in a fallopian tube cancer patient. (12618335)
Baudi F.... Venuta S.
|37|Fallopian tube cancer in a BRCA1 mutation carrier: rapid development and failure of screening. (11810084)
HAcbert-Blouin M.N.... Foulkes W.D.
|38|Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis. (11161856)
Paley P.J.... Goff B.A.
|39|Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. (11745677)
Piek J.M.... Verheijen R.H.
|40|Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass. (11205221)
Scholz H.S.... Petru E.
|41|Treatment of fallopian tube cancer. Review of the literature. (10985612)
Takeshima N.... Hasumi K.
|42|Diagnostic dilemmas and current therapy of Fallopian tube cancer. (10376425)
Ben-Hur H.... Hagay Z.
|43|Primary fallopian tube cancer: a review of the literature. (9643524)
|44|Fallopian tube cancer: incidence and role of lymphatic spread. (8751549)
di Re E.... Baiocchi G.
|45|Modulation of platinum sensitivity and resistance by cyclosporin A in refractory ovarian and fallopian tube cancer patients: a phase II study. (9816118)
Chambers S.K.... Chambers J.T.
|46|DNA-ploidy and mutant p53 overexpression in primary fallopian tube cancer. (11578443)
HellstrAPm A.C.... Auer G.
|47|Fallopian tube cancer metastatic to the breast. (8005136)
Fishman A.... Kaplan A.L.
|48|Staging rules for gestational trophoblastic tumors and fallopian tube cancer. (1317647)
|49|Immunolymphoscintigraphy and immunoscintigraphy of ovarian and fallopian tube cancer using F(ab')2 fragments of monoclonal antibody OC 125. (2297745)
Lehtovirta P.... SeppAolAo M.
Kimmel K.D.... Christman J.E.